Pomar, C.A.; Bonet, M.L.; Ferre-Beltrán, A.; Fraile-Ribot, P.A.; García-Gasalla, M.; Riera, M.; Picó, C.; Palou, A.
Increased mRNA Levels of ADAM17, IFITM3, and IFNE in Peripheral Blood Cells Are Present in Patients with Obesity and May Predict Severe COVID-19 Evolution. Biomedicines 2022, 10, 2007.
https://doi.org/10.3390/biomedicines10082007
AMA Style
Pomar CA, Bonet ML, Ferre-Beltrán A, Fraile-Ribot PA, García-Gasalla M, Riera M, Picó C, Palou A.
Increased mRNA Levels of ADAM17, IFITM3, and IFNE in Peripheral Blood Cells Are Present in Patients with Obesity and May Predict Severe COVID-19 Evolution. Biomedicines. 2022; 10(8):2007.
https://doi.org/10.3390/biomedicines10082007
Chicago/Turabian Style
Pomar, Catalina A., M. Luisa Bonet, Adrián Ferre-Beltrán, Pablo A. Fraile-Ribot, Mercedes García-Gasalla, Melchor Riera, Catalina Picó, and Andreu Palou.
2022. "Increased mRNA Levels of ADAM17, IFITM3, and IFNE in Peripheral Blood Cells Are Present in Patients with Obesity and May Predict Severe COVID-19 Evolution" Biomedicines 10, no. 8: 2007.
https://doi.org/10.3390/biomedicines10082007
APA Style
Pomar, C. A., Bonet, M. L., Ferre-Beltrán, A., Fraile-Ribot, P. A., García-Gasalla, M., Riera, M., Picó, C., & Palou, A.
(2022). Increased mRNA Levels of ADAM17, IFITM3, and IFNE in Peripheral Blood Cells Are Present in Patients with Obesity and May Predict Severe COVID-19 Evolution. Biomedicines, 10(8), 2007.
https://doi.org/10.3390/biomedicines10082007